The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
What Ryne Sandberg’s Story Reminds Us About Prostate Cancer
By The Cancer News Team
Baseball legend Ryne Sandberg’s battle with metastatic prostate cancer highlights the importance of early detection, awareness, and prevention for this common men’s cancer.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
New Biomarkers Predict Chemotherapy Resistance Across Multiple Cancer Types
By The Cancer News Team
New research identifies chromosomal instability (CIN) biomarkers that predict chemotherapy resistance across multiple cancer types, offering a breakthrough in precision oncology.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma
By Prakash Ambady, MD
FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Lung Cancer Prevention Strategies and Latest Therapies: World Lung Cancer Day Awareness 2025
By The Cancer News Team
Explore lung cancer prevention strategies, cutting-edge therapies, and expert insights from leading oncologists as we mark World Lung Cancer Day 2025.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Is Choosing Palliative Care Giving Up?
By Matthew Meranda, DO
Palliative care isn’t giving up—it’s a compassionate, patient-centered specialty focused on improving quality of life for those facing serious illness.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
Actor Robert Lowe Advocates for Increased Patient Participation in Cancer Clinical Trials
By The Cancer News Team
Actor Rob Lowe partners with Eli Lilly to raise awareness about cancer clinical trials, sharing a personal story of loss and hope to encourage patient advocacy and informed participation.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.
New Study Shows At-Home Cervical Cancer Screening Kits Outperform Office-Based Approach in Under-Resourced Health Care Setting
By The Cancer News Team
A landmark clinical trial shows mailed at-home cervical cancer screening kits significantly boost participation among underserved groups, addressing cancer health disparities and advancing global cervical cancer prevention efforts.
Top Oncology Innovations That Shaped the First Half of 2025
By Aishat Motolani, PhD
Breakthroughs in precision medicine, AI, and immunotherapy are redefining cancer care in 2025, offering new hope and improved outcomes for patients.
Top Oncology Innovations That Shaped the First Half of 2025
By Aishat Motolani, PhD
Breakthroughs in precision medicine, AI, and immunotherapy are redefining cancer care in 2025, offering new hope and improved outcomes for patients.
Top Oncology Innovations That Shaped the First Half of 2025
By Aishat Motolani, PhD
Breakthroughs in precision medicine, AI, and immunotherapy are redefining cancer care in 2025, offering new hope and improved outcomes for patients.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body
By The Cancer News Team
Researchers have developed a new method for generating CAR T cells inside the body using targeted lipid nanoparticles, potentially eliminating barriers that contribute to cancer health disparities.
Patients Over Politics: Why HHS Cuts Put Your Cancer Care at Risk
By Dr. Binay Shah
Dr. Binay Shah warns that deep HHS cuts will devastate cancer research, delay treatments, and widen disparities in care across underserved communities.
Patients Over Politics: Why HHS Cuts Put Your Cancer Care at Risk
By Dr. Binay Shah
Dr. Binay Shah warns that deep HHS cuts will devastate cancer research, delay treatments, and widen disparities in care across underserved communities.
Patients Over Politics: Why HHS Cuts Put Your Cancer Care at Risk
By Dr. Binay Shah
Dr. Binay Shah warns that deep HHS cuts will devastate cancer research, delay treatments, and widen disparities in care across underserved communities.